PortfoliosLab logo

ADC Therapeutics SA (ADCT)

Equity · Currency in USD · Last updated Aug 6, 2022

Company Info

ISINCH0499880968
CUSIP049988096
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$8.30
Year Range$5.96 - $31.51
EMA (50)$8.18
EMA (200)$14.37
Average Volume$291.96K
Market Capitalization$542.28M

ADCTShare Price Chart


Chart placeholderClick Calculate to get results

ADCTPerformance

The chart shows the growth of $10,000 invested in ADC Therapeutics SA in May 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $2,799 for a total return of roughly -72.01%. All prices are adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%MarchAprilMayJuneJulyAugust
-52.28%
-9.63%
ADCT (ADC Therapeutics SA)
Benchmark (^GSPC)

ADCTReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-6.21%8.19%
6M-47.30%-7.42%
YTD-58.91%-13.03%
1Y-65.14%-5.85%
5Y-43.61%18.11%
10Y-43.61%18.11%

ADCTMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-21.34%5.10%-12.04%-19.88%-41.89%16.23%-6.79%12.01%
2021-10.75%-6.93%-8.20%0.53%-11.78%12.47%-13.59%38.64%-6.89%6.74%-23.21%-9.25%
202024.62%26.68%-0.66%-5.01%-25.31%-13.03%30.05%-14.21%

ADCTSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ADC Therapeutics SA Sharpe ratio is -0.97. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00MarchAprilMayJuneJulyAugust
-0.97
-0.31
ADCT (ADC Therapeutics SA)
Benchmark (^GSPC)

ADCTDividend History


ADC Therapeutics SA doesn't pay dividends

ADCTDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-83.74%
-13.58%
ADCT (ADC Therapeutics SA)
Benchmark (^GSPC)

ADCTWorst Drawdowns

The table below shows the maximum drawdowns of the ADC Therapeutics SA. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ADC Therapeutics SA is 88.33%, recorded on Jun 16, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-88.33%Jul 6, 2020493Jun 16, 2022
-7.91%May 29, 20206Jun 5, 20204Jun 11, 202010
-3.03%Jun 15, 20203Jun 17, 20202Jun 19, 20205
-1.2%Jun 24, 20202Jun 25, 20202Jun 29, 20204
-0.71%May 27, 20201May 27, 20201May 28, 20202

ADCTVolatility Chart

Current ADC Therapeutics SA volatility is 60.39%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%MarchAprilMayJuneJulyAugust
60.39%
19.67%
ADCT (ADC Therapeutics SA)
Benchmark (^GSPC)